Given that it’s the time of year many celebrate an “immaculate conception” of two millennia ago, it’s seasonally appropriate to look at what’s happened to the Assisted Human Reproduction Act.

Life sciences research and innovation in Canada were given a significant boost by the federal government recently when it amended the Food and Drug Regulations Act to provide eight years of protection for clinical test data generated to approve a new medicine in Canada. This approval can also include six months of additional data protection for medicines that have been the subject of pediatric clinical trials.

Kudos to the Medical Post for highlighting connections between environmental degradation and illness. The public is indeed worried—and has been for some time.